The European landscape has seen a shifting evolution in the view of psychedelics. Long stigmatized, these substances have begun to be explored for their potential therapeutic applications. From Germany, where clinical trials are underway, to the Italy, where open conversations is expanding, Europe plays a leading role in this transformation of copy